BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) had its target price raised by research analysts at Wells Fargo & Company from $15.00 to $16.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price suggests a potential upside of 39.74% from the stock’s previous close.
A number of other research analysts have also recently weighed in on BTSG. UBS Group started coverage on shares of BrightSpring Health Services in a research note on Tuesday, February 20th. They set a “buy” rating and a $15.00 target price on the stock. SVB Leerink started coverage on BrightSpring Health Services in a research note on Tuesday, February 20th. They set an “outperform” rating and a $15.00 target price on the stock. Guggenheim assumed coverage on BrightSpring Health Services in a research note on Tuesday, February 20th. They issued a “buy” rating and a $15.00 price target for the company. Bank of America assumed coverage on shares of BrightSpring Health Services in a research report on Tuesday, February 20th. They set a “buy” rating and a $14.00 price objective on the stock. Finally, Morgan Stanley started coverage on shares of BrightSpring Health Services in a research note on Tuesday, February 20th. They set an “overweight” rating and a $18.00 target price for the company. Eleven research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $15.85.
Check Out Our Latest Report on BTSG
BrightSpring Health Services Trading Down 0.4 %
Shares of NASDAQ:BTSG traded down $0.05 during midday trading on Monday, hitting $11.45. The company had a trading volume of 360,829 shares, compared to its average volume of 2,075,316. The company has a debt-to-equity ratio of 5.73, a current ratio of 1.17 and a quick ratio of 0.84. The business has a fifty day simple moving average of $9.95. BrightSpring Health Services has a 12-month low of $7.85 and a 12-month high of $12.14.
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.06. The company had revenue of $2.58 billion during the quarter, compared to analysts’ expectations of $2.31 billion. During the same quarter in the previous year, the company earned ($0.10) EPS. The business’s quarterly revenue was up 27.0% compared to the same quarter last year. Sell-side analysts forecast that BrightSpring Health Services will post 0.67 EPS for the current year.
Insider Transactions at BrightSpring Health Services
In other BrightSpring Health Services news, insider James F. Mattingly, Jr. purchased 12,280 shares of the stock in a transaction that occurred on Thursday, March 14th. The stock was purchased at an average price of $8.18 per share, with a total value of $100,450.40. Following the acquisition, the insider now owns 128,700 shares in the company, valued at $1,052,766. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, insider James F. Mattingly, Jr. acquired 12,280 shares of the company’s stock in a transaction on Thursday, March 14th. The stock was bought at an average cost of $8.18 per share, with a total value of $100,450.40. Following the completion of the purchase, the insider now directly owns 128,700 shares of the company’s stock, valued at $1,052,766. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Jennifer A. Phipps acquired 12,300 shares of the business’s stock in a transaction on Thursday, March 14th. The shares were purchased at an average price of $8.14 per share, for a total transaction of $100,122.00. Following the transaction, the chief accounting officer now directly owns 165,618 shares of the company’s stock, valued at $1,348,130.52. The disclosure for this purchase can be found here.
Institutional Trading of BrightSpring Health Services
Large investors have recently made changes to their positions in the stock. Capstone Investment Advisors LLC bought a new stake in BrightSpring Health Services during the 1st quarter valued at $9,722,000. Seven Grand Managers LLC acquired a new position in shares of BrightSpring Health Services during the first quarter worth $1,630,000. Finally, BNP Paribas Financial Markets acquired a new position in BrightSpring Health Services during the 1st quarter valued at about $280,000.
About BrightSpring Health Services
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company’s platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Further Reading
Before you consider BrightSpring Health Services, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and BrightSpring Health Services wasn’t on the list.
While BrightSpring Health Services currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Which stocks are likely to thrive in today’s challenging market? Click the link below and we’ll send you MarketBeat’s list of ten stocks that will drive in any economic environment.
Source: marketbeat.com
